Specify a stock or a cryptocurrency in the search bar to get a summary
Granules India Limited
GRANULESGranules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India. Address: My Home Hub, Hyderabad, India, 500081
Analytics
WallStreet Target Price
58 415.24 INRP/E ratio
26.6019Dividend Yield
0.28 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures GRANULES
Dividend Analytics GRANULES
Dividend growth over 5 years
50 %Continuous growth
1 yearPayout Ratio 5 years average
8 %Dividend History GRANULES
Stock Valuation GRANULES
Financials GRANULES
Results | 2019 | Dynamics |